Julie Grisham, MS

Freelance Science Writer

Recent Blog Posts

Pictured: Luciano Martelotto, Catherine Cowell & Jorge Reis-Filho
Profile
Monday, August 5, 2013

Jorge Reis-Filho studies the genetic alterations that drive the malignant behavior of cells in rare types of breast cancer.

Pictured: Philip Gutin
Cancer Guide
Monday, July 15, 2013

Memorial Sloan Kettering’s Brain Tumor Center provides world-class care to people with low-grade glioma, a type of slow-growing brain tumor.

Pictured: Christina Leslie
Profile
Friday, June 28, 2013

Christina Leslie develops computational and statistical methods to study gene expression in normal cells and in cancer cells.

Pictured:  Timothy Chan
In the Lab
Friday, May 24, 2013

Investigators have sequenced the genome of adenoid cystic carcinoma, a rare and deadly head and neck cancer. The work sets the stage for the sequencing of additional rare cancers at Memorial Sloan Kettering.

Pictured: Steven Wang
Ask the Expert
Wednesday, May 15, 2013

In this “Ask the Expert” feature, dermatologist Steven Wang discusses how to choose the most effective sunscreen.

Pictured: Charles Sawyers
In the Lab
Tuesday, April 30, 2013

Research suggests that a new drug could be effective in patients with prostate cancer who develop resistance to the targeted therapy enzalutamide.

Pictured: Gary Schwartz & Mark Dickson
In the Clinic
Monday, April 22, 2013

Two clinical trials of targeted therapies led by Memorial Sloan Kettering investigators show promising results against different types of sarcoma.

Pictured: Megan Harlan Fleischut & Kenneth Offit
Q&A
Monday, April 15, 2013

Genetic counselor Megan Harlan Fleischut discusses hereditary cancers and the services offered by Memorial Sloan Kettering’s clinical genetics experts.

Pictured: Virtual Programs
Event
Friday, April 12, 2013

Memorial Sloan Kettering’s Virtual Programs offers patients private, online support and education sessions to participate in from home or work.

Pictured: José Baselga
Finding
Monday, April 8, 2013

Memorial Sloan Kettering’s Physician-in-Chief, José Baselga, explains the findings from three studies on new targeted therapies for breast cancer.

Pictured: Kenneth Offit
Finding
Thursday, March 28, 2013

A study identifies genetic variations that alter the risk of breast cancer in women who have a certain gene mutation.

Pictured: ESK1 Monoclonal Antibody
In the Lab
Wednesday, March 13, 2013

Scientists from Memorial Sloan Kettering have collaborated on the discovery of a unique monoclonal antibody, called ESK1, that appears to be effective at targeting and destroying several types of cancer cells.

Pictured: Massage Therapy
In the Clinic
Monday, March 4, 2013

Peripheral neuropathy — a nerve disorder that can cause weakness, numbness, tingling, and pain — is a common chemotherapy side effect. Treatments are available to help improve your quality of life.

Pictured: Major Trends in Modern Cancer Research Seminar
Video
Friday, March 1, 2013

At the seventh annual seminar for high school students and teachers, investigators discuss how cutting-edge biomedical research may ultimately contribute to better treatments for cancer patients.

Pictured: Prasad Adusumilli
In the Lab
Thursday, January 3, 2013

A team from Memorial Sloan Kettering has found that the makeup of immune cells in a lung tumor and in tissue surrounding a tumor can predict whether the cancer will recur after surgery.